Augmentin '125' and Slow-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin '125' (amoxicillin; clavulanate potassium) and Slow-k (potassium chloride). Common drug interactions include haematocrit decreased among females and tachycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin '125' and Slow-k. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Slow-k?

Slow-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 3,683 Slow-k users. Check the latest studies of Slow-k.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

17 people who take Augmentin '125' and Slow-k together, and have interactions are studied.

Augmentin '125' and Slow-k drug interactions.

What are the common drug interactions of Augmentin '125' and Slow-K, by gender? *:

female:

Haematocrit decreased
Haemoglobin decreased
Hepatitis (inflammation of the liver)
Hepatitis b surface antigen positive
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Injection site erythema (redness at injection site)
Injury
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Lung disorder (lung disease)

male:

Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Blood potassium decreased
Pulmonary embolism (blockage of the main artery of the lung)
Amaurosis fugax (painless transient monocular visual loss)
Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Apnoea (suspension of external breathing)
Asthenia (weakness)
Atelectasis (partial or complete collapse of the lung)

What are the common drug interactions of Augmentin '125' and Slow-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Pneumonia
Alanine aminotransferase increased
Aspartate aminotransferase increased
Bilirubin conjugated increased
Cardiac failure
Hyperbilirubinaemia (excess of bilirubin in the blood)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
Lung disorder (lung disease)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Dyspnoea (difficult or laboured respiration)
Haematocrit decreased
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Decreased appetite
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Apnoea (suspension of external breathing)
Asthenia (weakness)
Atelectasis (partial or complete collapse of the lung)
Back pain

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 5 people, 29.41%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
High Blood Cholesterol: 2 people, 11.76%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 2 people, 11.76%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
Asthma: 2 people, 11.76%
High Blood Pressure: 1 person, 5.88%
Hiv Infection: 1 person, 5.88%
Insomnia (sleeplessness): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and Slow-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously